​

Medline (MDLN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

MDLN Stock Forecast

Medline (MDLN) stock forecast, based on 10 Wall Street analysts, predicts a 12-month average price target of $48.59, with a high of $56.00 and a low of $38.00. This represents a 6.35% increase from the last price of $45.69.

MDLN Stock Rating

Medline stock's rating consensus is Buy, based on 10 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (90.00%), 1 Hold (10.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 10 0 1 9 Strong Sell Sell Hold Buy Strong Buy

MDLN Price Target Upside V Benchmarks

TypeNameUpside
StockMedline6.35%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks23.73%

Price Target Trends

1M3M12M
# Anlaysts-2525
Avg Price Target-$48.52$48.52
Last Closing Price$45.69$45.69$45.69
Upside/Downside-6.19%6.19%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 266175--28
Mar, 266165--27
Feb, 265165--26
Jan, 2645---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 09, 2026Ivan FeinsethTigress Financial$60.00$43.4138.22%31.32%
Feb 25, 2026Michael ChernyLeerink Partners$56.00$48.1816.23%22.57%
Feb 25, 2026Stifel Nicolaus$55.00$48.1814.16%20.38%
Feb 25, 2026Evercore ISI$55.00$49.3811.38%20.38%
Feb 05, 2026Tigress Financial$55.00$45.0122.20%20.38%
Jan 21, 2026David LarsenJ.P. Morgan$55.00$43.1727.40%20.38%
Jan 12, 2026Barclays$50.00$41.6520.05%9.43%
Jan 12, 2026BNP Paribas$38.00$42.19-9.93%-16.83%
Jan 12, 2026Wolfe Research$47.00$41.8812.23%2.87%
Jan 12, 2026Deutsche Bank$40.00$40.52-1.28%-12.45%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 25, 2026Evercore ISIOutperformOutperformhold
Feb 05, 2026Tigress FinancialBuyinitialise
Jan 21, 2026BTIGBuyBuyhold
Jan 12, 2026CitigroupBuyinitialise
Jan 12, 2026BarclaysOverweightinitialise
Jan 12, 2026Exane BNP ParibasNeutralinitialise
Jan 12, 2026Wolfe ResearchOutperforminitialise
Jan 12, 2026Deutsche BankHoldinitialise
Jan 12, 2026Cowen & Co.Buyinitialise
Jan 12, 2026BTIGBuyinitialise

Financial Forecast

EPS Forecast

Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$1.21$1.48
High Forecast$1.31$1.52
Low Forecast$1.18$1.42
Surprise %--

Revenue Forecast

$28B $28B $29B $30B $30B $31B Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$28.14B$30.52B
High Forecast$28.18B$30.98B
Low Forecast$27.98B$30.15B
Surprise %--

Net Income Forecast

$900M $960M $1B $1B $1B $1B Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$950.74M$1.16B
High Forecast$1.03B$1.20B
Low Forecast$928.80M$1.12B
Surprise %--

MDLN Forecast FAQ

Is Medline stock a buy?

Medline stock has a consensus rating of Buy, based on 10 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medline is a favorable investment for most analysts.

What is Medline's price target?

Medline's price target, set by 10 Wall Street analysts, averages $48.59 over the next 12 months. The price target range spans from $38 at the low end to $56 at the high end, suggesting a potential 6.35% change from the previous closing price of $45.69.

How does Medline stock forecast compare to its benchmarks?

Medline's stock forecast shows a 6.35% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (23.73%).

What is the breakdown of analyst ratings for Medline over the past three months?

  • April 2026: 21.43% Strong Buy, 60.71% Buy, 17.86% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 22.22% Strong Buy, 59.26% Buy, 18.52% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 19.23% Strong Buy, 61.54% Buy, 19.23% Hold, 0% Sell, 0% Strong Sell.

What is Medline’s EPS forecast?

Medline's average annual EPS forecast for its fiscal year ending in December 2025 is $1.21, marking a 0% decrease from the reported - in 2024. Estimates for the following years are.

What is Medline’s revenue forecast?

Medline's average annual revenue forecast for its fiscal year ending in December 2025 is $28.14B, reflecting a 0% decrease from the reported - in 2024. The forecast for.

What is Medline’s net income forecast?

Medline's net income forecast for the fiscal year ending in December 2025 stands at $950.74M, representing a 0% decrease from the reported - in 2024. Projections indicate .